Karyopharm Therapeutics Inc 10-Q for FY2026 Q2
Karyopharm Therapeutics Inc. (KPTI)
10-Q
2026-08-13
For: 2026-06-30
View Original
Added on
August 13, 2026
About this 10-Q
Karyopharm Therapeutics Inc filed this 10-Q on August 13, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $33.43M
- down 11.9% from $37.93M a year earlier
- Net loss
- $67.02M
- compared with a net loss of $37.25M a year earlier
- Diluted EPS
- -$2.32
- compared with -$4.32 a year earlier